Delivery Order SPE2DB20D7059-SPE2DB24FQMW5
Award Date
9/16/24
Potential Completion Date
9/17/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DX15D3003|SPE2DX24F5Q1W, was granted by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,170.81 firm fixed-price delivery order is for the supply of 4565586221 FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024 and was awarded on August 26, 2024. Amerisourcebergen, as a major pharmaceutical...
This federal contract award, with ID SPE2DB20D3101|SPE2DB22FH8U4, is for the delivery of FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML medication to the Defense Logistics Agency (DLA). The $2,125.92 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 18, 2022, with a completion date of February 22, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product. The $2,184.96 firm fixed-price delivery order has an ultimate completion date of August 10, 2022. The contract is not designated as a set-aside award. AmerisourceBergen, a for-profit organization, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,737.56 firm fixed-price delivery order is for the supply of FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product. The contract has a completion date of December 5, 2022 and was awarded on December 2, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
The Defense Logistics Agency (DLA) awarded a $1,092.48 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a pharmaceutical product, specifically 4564490684 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML. The award has a ceiling value of $1,188.42 and was issued as a Delivery Order under a Firm Fixed Price contract. The contracting agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,144.40 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the provision of FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.21 Firm Fixed Price Delivery Order is for the supply of FIRST-OMEPRAZOLE 2 MG/ML SUSP 300ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
This federal contract award, identified as SPE2DX15D6028|SPE2DX24FWMDG, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,317.10 firm fixed-price delivery order is for the supply of OMEPRAZ 2.5MG SUSP 30S, a pharmaceutical product, with a completion date of April 15, 2024. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, holds a...
This federal contract award, valued at $3,277.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product called FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, which is likely a medication used for treating conditions related to the stomach and digestive system. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on...